Yossepowitch O - Search Results

1

The very-high-risk prostate cancer: a contemporary update.

Mano R, Eastham J, Yossepowitch O. Mano R, et al. Among authors: yossepowitch o. Prostate Cancer Prostatic Dis. 2016 Dec;19(4):340-348. doi: 10.1038/pcan.2016.40. Epub 2016 Sep 13. Prostate Cancer Prostatic Dis. 2016. PMID: 27618950 Free PMC article. Review.

2

Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy.

Eggener SE, Roehl KA, Yossepowitch O, Catalona WJ. Eggener SE, et al. Among authors: yossepowitch o. J Urol. 2006 Oct;176(4 Pt 1):1399-403. doi: 10.1016/j.juro.2006.06.045. J Urol. 2006. PMID: 16952643

3

The natural history of noncastrate metastatic prostate cancer after radical prostatectomy.

Yossepowitch O, Bianco FJ Jr, Eggener SE, Eastham JA, Scher HI, Scardino PT. Yossepowitch O, et al. Eur Urol. 2007 Apr;51(4):940-7; discussion 947-8. doi: 10.1016/j.eururo.2006.10.045. Epub 2006 Oct 30. Eur Urol. 2007. PMID: 17125912 Free PMC article.

4

Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.

Yossepowitch O, Eggener SE, Bianco FJ Jr, Carver BS, Serio A, Scardino PT, Eastham JA. Yossepowitch O, et al. J Urol. 2007 Aug;178(2):493-9; discussion 499. doi: 10.1016/j.juro.2007.03.105. Epub 2007 Jun 11. J Urol. 2007. PMID: 17561152

5

Radical prostatectomy shortly after prostate biopsy does not affect operative difficulty or efficacy.

Eggener SE, Yossepowitch O, Serio AM, Vickers AJ, Scardino PT, Eastham JA. Eggener SE, et al. Among authors: yossepowitch o. Urology. 2007 Jun;69(6):1128-33. doi: 10.1016/j.urology.2007.01.089. Urology. 2007. PMID: 17572200

6

Advanced but not localized prostate cancer is associated with increased oxidative stress.

Yossepowitch O, Pinchuk I, Gur U, Neumann A, Lichtenberg D, Baniel J. Yossepowitch O, et al. J Urol. 2007 Oct;178(4 Pt 1):1238-43; discussion 1243-4. doi: 10.1016/j.juro.2007.05.145. Epub 2007 Aug 14. J Urol. 2007. PMID: 17698111

7

Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy.

Yossepowitch O, Eggener SE, Serio AM, Carver BS, Bianco FJ Jr, Scardino PT, Eastham JA. Yossepowitch O, et al. Eur Urol. 2008 May;53(5):950-9. doi: 10.1016/j.eururo.2007.10.008. Epub 2007 Oct 12. Eur Urol. 2008. PMID: 17950521 Free PMC article.

8

Low risk prostate cancer in men under age 65: the case for definitive treatment.

Jang TL, Yossepowitch O, Bianco FJ Jr, Scardino PT. Jang TL, et al. Among authors: yossepowitch o. Urol Oncol. 2007 Nov-Dec;25(6):510-4. doi: 10.1016/j.urolonc.2007.05.025. Urol Oncol. 2007. PMID: 18047962 Free PMC article. Review.

9

Radical prostatectomy for high-risk prostate cancer.

Yossepowitch O, Eastham JA. Yossepowitch O, et al. World J Urol. 2008 Jun;26(3):219-24. doi: 10.1007/s00345-008-0247-2. Epub 2008 Mar 12. World J Urol. 2008. PMID: 18335221 Review.

10

Role of radical prostatectomy in the treatment of high-risk prostate cancer.

Yossepowitch O, Eastham JA. Yossepowitch O, et al. Curr Urol Rep. 2008 May;9(3):203-10. doi: 10.1007/s11934-008-0036-x. Curr Urol Rep. 2008. PMID: 18765114 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters